We have tabulated the series of steps in infusion rate required to maintain constant arterial levels of thiopentone and methohexitone. The tables are based on multi exponential equations for infusion rate, derivedfram plasma drug efflux studies. In each table an initial bolus isfollowed by nine steps in infusion rate over three hours. The tables provide rates suitable for delivery by a standard syringe pump to achieve and maintain an arterial concentration of 10 mg/l of thiopentone and 5 mg/l of methohexitone. Other desired drug concentrations can be derivedfram the table by simple multiplication.
Infusion profiles for maintaining constant arterial concentrations of thiopentone and methohexitone have been described recently. I There are several advantages ifit is possible to achieve a constant, known arterial concentration of thiopentone or methohexitone.
First, it is possible, with a relatively constant concentration, for the anaesthetist to assess anaesthetic requirements in the absence of the rapid fluctuations characteristic of bolus injection. 2 It has been reported that arterial concentrations of 8-12 mg/l of thiopentone are required for controlled ventilation with neuromuscular blockade 3 and 15-17 mg/l is required for spontaneous breathing. 4 Second, the use of intravenous drugs on a routine basis is simplified as the chance of overdose or underdose is lessened considerably. This technique also reduces the total amount of drug required and as a result brings a more rapid recovery.
Generally the use of thiopentone and methohexitone is limited to induction of anaesthesia, but it can be also indicated in general anaesthesia, neuroanaesthesia 5 and cardiac anaesthesia, 6 with the benefit of cerebral protection, 7 as well as in treatment of seizures and sedation in intensive care units. 5 With infusion rates based on averaged patient data, fine control of the effect of intravenous anaesthetics can be achieved in a manner largely analogous to the use of a calibrated vaporiser for delivery of volatile anaesthetic agents.
METHODS Although the development of a programmable infusion pump is highly
Anaesthesia and Intensil'e Care, Vol. 17, No. 4, NOl'ember, 1989 desirable, such a device is not generally available. However, it is a relatively simple task to convert published infusion profiles, derived either from a conventional pharmacokinetic modeF or from plasma drug effiux profiles, I into a series of steps.
Patient size
The lean body mass (LBM in kg) is used as the basis of scaling the infusion to patient size. I The size of each patient is estimated, using height (Ht in cm), total body weight (TBW in kg) and sex according to the following equations: (2) Alternatively, using the older Imperial System for linear measurement, per cent fat (F) and then lean body mass (LBM in kg) can be calculated from height (H in inches), girth at the umbilicus (G in inches) and total body weight (TBW in kg) from the formulae: 8 Figure 1 (A) is a graphical representation of the equation for the plasma drug effiux of thiopentone achieved by an iterative approach in patients undergoing both general surgery and cardiac surgery. I The equation used to describe the effiux of thiopentone and ~ence to achieve a constant arterial drug level IS:
Infusion profile for thiopentone
Elt) = 25.35e-0.145t + 4.85e-0.0148t + 8.8 (5) where Ep(t) is plasma drug effiux (ml/minl kgLBM) and t is time (min) of infusion. Ep(t) represents conventional clearance at the steady state, plus the 'net clearance' of drug from the plasma to various tissues. Superimposed in Figure 1 (A) is a series of steps in infusion rate where the time scale was divided into nine intervals. Initially intervals are of five minutes' duration in order to follow the steep part of the Ep(t) curve. They are increased to 10 minutes from 10 until 30 minutes and 30 minutes from then on as the equation becomes less steep. In the early part of the curve, for example in the first interval from 0 to 5 minutes, Ep(t) values at 0.5, 1.5, 2.5,3.5 and 4.5 minutes were 37.2, 33.9, 31.1, 28.7, 26.5 mllmin/kgLBM respectively, resulting in an average Ep(t) of 31.5 mllminlkgLBM.
Scaling of the steps to a specific arterial concentration Ca (mgll), a syringe concentration Cs (mg/ml) and a specific patient size expressed in kgLBM is achieved as follows:
Required fluid flow . V(mllhr) = Q(mglmin) X 60 (7) Cs(mg/ml) Then, for the first period, the required infusion rate of thiopentone to achieve a concentration of 10 mgll in a patient of 35 kgLBM is given by: Q= 31.5 X 10 X 35 = 110 (mglmin)
. 
The calculation is then repeated at each interval and for a range of patient LBM to make the entire table (Table 1) .
Bolus dose
As described previously! a bolus dose of thiopentone of 2 mg/kg over 15 seconds must be given to provide initial loading for a 10 mg/I maintained arterial concentration. This rate of delivery is in excess of the delivery rate of most syringe pumps and can be given manually at the commencement of the infusion. Therefore the volumes of 0.08 mllkgLBM are specified for the desired concentration of 10 mg/l and listed in Table 1 . Table 1 provides doses and delivery rates necessary to establish and maintain a desired thiopentone concentration at 10 mg/1.
Use of table
Other desired concentrations can be derived by scaling each value accordingly. For instance, with a female patient of 170 cm height and 70 kg TBM requiring thiopentone and nitrous oxide anaesthetic at a desired concentration of 15 mg/l, the following calculations are required. From equation (2) using Table 1 the initial bolus dose will be 4 ml of 2.5% thiopentone, but the bolus dose and each infusion rate in the column for 50 kgLBM must be multiplied by 15/10. The resulting values will be 6 ml bolus injection, 56.7 ml/hr at 0-5 minutes, 39.6 ml/hr at 5-10 minutes, 28.5 ml/hr at 10-20 minutes, and so on.
Infusion profile for methohexitone
For methohexitone! the equation for the plasma drug efflux (mllmin/kgLBM) is:
This equation is presented graphically in Figure 1 (B) . The intervals are the same as those for thiopentone because the shape of the efflux curve is similar. The average Ep(t) is calculated as described for thiopentone, and then scaled for the standard solution of 10 mg/ml and a desired arterial concentration of 5 mg/1. The bolus injection dose of 1 mg/kgLBM is used for a desired concentration of 5 mg/I.! The resulting values are presented in Table 2 .
Our experience suggests methohexitone should be used in the range of 4-9 mg/l and only with neuromuscular junction blockade. Above this range excitatory phenomena appear, making this drug unsuitable for spontaneous ventilation. Furthermore, these excitatory phenomena make any infusions of methohexitone in neurosurgery and in epileptics contraindicated. 
CONCLUSION
The tables presented in this short communication should be of value for implementing infusions of thiopentone and methohexitone with standard syringe infusion pumps.
